Inspire Appoints Brett Kleger as New CEO

Brett Kleger, CEO, Inspire Photo Credit: Inspire via Newswire

ARLINGTON, Va., June 7, 2024 (VSNewsNetwork.com) - Inspire, an online health community and real-world data platform, has announced the appointment of Brett Kleger as Chief Executive Officer, effective June 5, 2024.

“We are thrilled to welcome Brett to Inspire,” said Dan Levine, managing director of Tenfore Holdings and an Inspire Board member. “He is a seasoned and innovative executive who has taken several companies from infancy to market leader. He joins Inspire as the company is experiencing rapid growth in its real-world evidence and patient clinical trial recruitment solutions and continues to expand its patient engagement and advertising portfolios.”

Levine added, “Inspire is a unique community with a critical role to play in both patient experiences and the clinical drug R&D ecosystem. Brett will bring a wealth of experience and knowledge to help accelerate Inspire’s growth at this pivotal stage.”

Kleger’s most recent position was as CEO of Datacubed Health, where he guided the company from early-stage concepts to a significant player in the electronic clinical outcomes assessment (eCOA) and decentralized clinical trial platform categories. Prior to Datacubed, Kleger served as Chief Commercial Officer and Chief Operating Officer at DrugDev, leading the company's development to become the leading provider of site-facing technologies, which eventually led to its acquisition by IQVIA. Following the acquisition, Kleger stayed with IQVIA for several years, leading the commercialization of its clinical trial technologies.

“I am thrilled to join Inspire at this pivotal time,” said Kleger. “The company is unique in its robust community of engaged members and volume and depth of patient voice data. Inspire offers clients unparalleled access to information and patient insights that can fuel health advances. The company is already on an upward trajectory with an incredible team and customer base, and I’m looking forward to leading the company to even greater levels of growth.”

Kleger holds a business degree from the University of Maryland and a juris doctorate from the Villanova School of Law. In 2018, he was named to the prestigious PharmaVoice 100, recognizing his significant career achievements.

For more information, visit about.Inspire.com.

Source: Inspire via Newswire